SeaStar Medical (NASDAQ:ICU) Releases Earnings Results, Beats Estimates By $0.38 EPS

SeaStar Medical (NASDAQ:ICU) issued its earnings results on Tuesday. The company reported ($1.03) earnings per share for the quarter, topping the consensus estimate of ($1.41) by $0.38, Zacks reports.

SeaStar Medical Price Performance

Shares of NASDAQ ICU traded up $1.24 during mid-day trading on Thursday, reaching $6.25. The company’s stock had a trading volume of 156,780 shares, compared to its average volume of 244,495. The stock has a fifty day moving average of $7.22 and a two-hundred day moving average of $13.47. The firm has a market capitalization of $20.13 million, a PE ratio of -0.23 and a beta of -1.07. SeaStar Medical has a 52 week low of $3.25 and a 52 week high of $42.92.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.